1. Health Canada assesses risk of drug interactions with Jakavi

   News item 20 October 2018 Pages: 1 - 1

2. Phase III trial of rivaroxaban (Xarelto) prematurely stopped

   Correspondence 20 October 2018 Pages: 2 - 2

3. Alzheimer's disease: stroke with antiepilepetic drugs

   Clinical study 20 October 2018 Pages: 3 - 3

4. Cardiovascular disease with adjuvant endocrine therapy

   Clinical study 20 October 2018 Pages: 4 - 4

5. Drug interaction test reduces outpatient visits and costs

   Clinical study 20 October 2018 Pages: 5 - 5

6. News from 19th World Conference on Lung Cancer

   News item 20 October 2018 Pages: 6 - 7

7. Pharmacovigilance centres: drug safety during pregnancy

   Clinical study 20 October 2018 Pages: 7 - 7

8. PPIs increase risks of hepatic encephalopathy and mortality

   Clinical study 20 October 2018 Pages: 8 - 8

9. Real-world rates and costs of EGFR-TKI-related adverse events

   Clinical study 20 October 2018 Pages: 9 - 9

10. Rheumatic immune-related AEs with checkpoint inhibitors

    Clinical study 20 October 2018 Pages: 10 - 10

11. Venous thromboembolism with continuous cycle OCs

    Clinical study 20 October 2018 Pages: 11 - 11

12. Aceclofenac

    Case report 20 October 2018 Pages: 12 - 12

13. Aciclovir

    Case report 20 October 2018 Pages: 13 - 13

14. Adalimumab

    Case report 20 October 2018 Pages: 14 - 14

15. Adalimumab

    Case report 20 October 2018 Pages: 15 - 15

16. Adalimumab/etanercept

    Case report 20 October 2018 Pages: 16 - 16

17. Adalimumab/infliximab

    Case report 20 October 2018 Pages: 17 - 17

18. Adalimumab/methotrexate

    Case report 20 October 2018 Pages: 18 - 18

19. Adalimumab/methotrexate/prednisolone

    Case report 20 October 2018 Pages: 19 - 19

20. Alcohol

    Case report 20 October 2018 Pages: 20 - 20

21. Alemtuzumab

    Case report 20 October 2018 Pages: 21 - 21

22. Alemtuzumab/immunosuppressants

    Case report 20 October 2018 Pages: 22 - 22

23. Alfacalcidol

    Case report 20 October 2018 Pages: 23 - 23

24. Alprazolam

    Case report 20 October 2018 Pages: 24 - 24

25. Alteplase

    Case report 20 October 2018 Pages: 25 - 25

26. Amiodarone

    Case report 20 October 2018 Pages: 26 - 26

27. Amiodarone

    Case report 20 October 2018 Pages: 27 - 27

28. Amiodarone/contrast media

    Case report 20 October 2018 Pages: 28 - 28

29. Amiodarone/rifampicin interaction

    Case report 20 October 2018 Pages: 29 - 29

30. Amlodipine

    Case report 20 October 2018 Pages: 30 - 30

31. Amlodipine/nivolumab

    Case report 20 October 2018 Pages: 31 - 31

32. Amoxicillin/clavulanic acid

    Case report 20 October 2018 Pages: 32 - 32

33. Amoxicillin/clindamycin

    Case report 20 October 2018 Pages: 33 - 33

34. Amphotericin-B

    Case report 20 October 2018 Pages: 34 - 34

35. Amphotericin-B-liposomal/flucytosine

    Case report 20 October 2018 Pages: 35 - 35

36. Anakinra/colchicine

    Case report 20 October 2018 Pages: 36 - 36

37. Anti-platelets/anti-thrombotics

    Case report 20 October 2018 Pages: 37 - 37

38. Antibacterials/thrombin/voriconazole

    Case report 20 October 2018 Pages: 38 - 38

39. Anticoagulants

    Case report 20 October 2018 Pages: 39 - 39

40. Antineoplastics

    Case report 20 October 2018 Pages: 40 - 40

41. Antineoplastics

    Case report 20 October 2018 Pages: 41 - 41

42. Antineoplastics

    Case report 20 October 2018 Pages: 42 - 42

43. Antineoplastics

    Case report 20 October 2018 Pages: 43 - 43

44. Antineoplastics

    Case report 20 October 2018 Pages: 44 - 44

45. Antineoplastics/antiulcers

    Case report 20 October 2018 Pages: 45 - 45

46. Antineoplastics/bisphosphonates/denosumab

    Case report 20 October 2018 Pages: 46 - 46

47. Antineoplastics/cotrimoxazole

    Case report 20 October 2018 Pages: 47 - 47

48. Antipsychotics

    Case report 20 October 2018 Pages: 48 - 48

49. Antipsychotics/anxiolytics/biperiden

    Case report 20 October 2018 Pages: 49 - 49

50. Antiretrovirals

    Case report 20 October 2018 Pages: 50 - 50